PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1629305
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1629305
Vascular Grafts Market size was valued at USD 1,745.34 Million in 2023, expanding at a CAGR of 7.3% from 2024 to 2032.
Vascular grafts are medical devices that aim at replacing or bypassing diseased or damaged vessels inside the human body. These grafts are implanted under surgery for normal restoration of blood flow and hence help prevent the complications occurring in vascular diseases, mainly coronary arteries, peripheral arterial disease, and renal system failure. The primary purpose of a vascular graft is to act as a conduit for blood flow if natural vessels cannot function properly because of blockages, injuries, or structural defects. These grafts are widely used in CABG, hemodialysis access, and aneurysm repair. The use of vascular grafts has become paramount in the management of growing cases of vascular diseases fueled by factors such as growing old populations, sedentary lifestyles, and a growing number of chronic diseases such as diabetes and hypertension. As the need for efficient and long-term vascular interventions grows, innovations in materials, techniques, and graft design continue to be made, improving the life of these saving devices.
Vascular Grafts Market- Market Dynamics
The propelling prevalence of cardiovascular diseases (CVDs) and vascular disorders drives the vascular grafts market. According to the World Health Organization, CVDs are the leading cause of global mortality, responsible for nearly 31% of all deaths. The ageing population, especially in developed nations, is witnessing an increasing demand for vascular surgeries, and elderly patients are more liable to peripheral artery disease, coronary artery disease, and renal failure. Lifestyle-related conditions such as diabetes and hypertension, leading to vascular damage, are also gaining prevalence and market growth. Technological developments in graft materials have improved their outcomes and extended the duration of use for these medical devices, fueling the market growth.
Major opportunities through vascular grafts include bioresorbable graft development and hybrid graft, as these can allow for integration with the natural tissue of the body and minimize complications. New growth opportunities are emerging in the Asia-Pacific and Latin American markets because health care infrastructures are becoming more advanced, and advanced medical technologies demand is expected to increase. Companies also focus on minimally invasive surgical techniques, which are expected to grow rapidly, offering less recovery time and fewer patient complications. However, vascular graft surgery entails high procedural costs and the risks of complications associated with this graft failure, infection, and rejection, inhibit market growth in some of the regions. Moreover, regulatory hurdles & protracted approval timelines for incorporating new materials and devices also challenge market growth.
Vascular Grafts Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.3% over the forecast period (2024-2032)
Based on product segmentation, hemodialysis access graft was predicted to show maximum market share in the year 2023
Based on application segmentation, Coronary artery disease (CAD) was the leading application in 2023
Based on region, North America was the leading revenue generator in 2023
The Global Vascular Grafts Market is segmented based on Product, Application, Material, End Use, and Region.
By product, the global vascular grafts market is divided into endovascular stent graft, hemodialysis access graft, bypass graft, peripheral vascular graft, and others. The hemodialysis access graft is the largest segment in the global vascular grafts market due to the increasing prevalence of CKD. The National Kidney Foundation estimated that approximately 37 million Americans suffer from CKD, and many of them undergo hemodialysis for kidney failure. Hemodialysis access grafts, used to create a durable access point for dialysis, are critical in managing such patients. The growth in the segment is primarily due to increasing demand for dialysis treatments and an elderly population, which is more susceptible to kidney diseases. Advances in graft materials, including synthetic and hybrid options, have helped improve graft performance and patient outcomes, thus solidifying the leading position of the hemodialysis access graft segment. The endovascular stent graft segment is growing the fastest during the forecast period. This segment is expanding at a rapid pace because of the rising incidence of aortic aneurysms and a preference for minimally invasive procedures. This has revolutionized the treatment of abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAA), making it possible for patients to recover more quickly and minimize the risks of complications. Technological innovations, such as custom-made grafts and the increasing availability of these stents in developed and emerging markets, also support fast growth in this segment.
By application, the global vascular grafts market is divided into coronary artery disease, vascular occlusion, renal failure, aneurysm, and others. Coronary artery disease (CAD) is the largest segment in the vascular grafts market, due to the high prevalence of cardiovascular diseases among people globally. The WHO cites that CVDs result in 31% of deaths worldwide. The main contributing factor to this demand is increasing aging populations, a sedentary lifestyle, and more cases of risk factors that include hypertension, diabetes, and smoking. Coronary artery bypass grafting remains one of the most common surgical interventions, and vascular grafts will continue to be in great demand as more people will need long-term interventions for the restoration of blood flow to the heart. The aneurysm segment is the most rapidly growing application, since there is an increasing incidence of aortic aneurysms, especially abdominal and thoracic aneurysms. According to the CDC, the incidence of abdominal aortic aneurysms has increased by 4.8% annually over the last decade. Minimally invasive endovascular stent grafts have become the preferred treatment option because they have reduced recovery times and lower complication rates than traditional surgical approaches.